Jodi Regts | VP, Corporate Affairs & IR |
Simon Pimstone | CEO & Director |
Ian Mortimer | President, CFO, COO & Company Secretary |
Paul Matteis | Stifel, Nicolaus & Company |
Lachlan Hanbury-Brown | William Blair & Company |
Yatin Suneja | Guggenheim Securities |
Maurice Raycroft | Jefferies |
Ladies and gentlemen, thank you for standing by, and welcome to the Xenon Pharmaceuticals 2019 Financial Results Earnings Call. [Operator Instructions].
As a reminder, today's program is being recorded. I would now like to introduce your host for today's program, Jodi Regts. Please go ahead.